Dilemma of Dantrolene: A life-saving drug unavailable in Pakistan

Authors

  • Tahir Ali
  • Habib Feroz Kapadia

DOI:

https://doi.org/10.51985/JBUMDC2022137

Abstract

Malignant hyperthermia (MH) is brought on by a number
of anaesthetic drugs, primarily succinylcholine and inhalation
anesthetics.1 It is a hypermetabolic reaction in those who
are genetically predisposed

References

Blais A. Succinylcholine, malignant hyperthermia and

rhabdomyolysis. CMAJ. 2022;194(25):E878. DOI: https://doi.

org/10.1503/cmaj.146480-l

Neto CN, Neville MF, da Silva HC. Anesthesia for malignant

hyperthermia susceptible patients. InTreatments, Mechanisms,

and Adverse Reactions of Anesthetics and Analgesics 2022

(pp. 3-14). Academic Press. https://doi.org/10.1016/B978-0-

-820237-1.00001-6

Dar IS, Ashraf M. Pathophysiology of malignant hyperthermia.

Perioperative Anaesthetic Emergencies. 2021:272.

Bin X, Wang B, Tang Z. Malignant Hyperthermia: A Killer

If Ignored. Journal of PeriAnesthesia Nursing. 2022 Apr 10.

https://doi.org/10.1016/j.jopan.2021.08.018

Hopkins PM, Girard T, Dalay S, Jenkins B, Thacker A, Patteril

M, McGrady E. Malignant hyperthermia 2020: Guideline

from the Association of Anaesthetists. Anaesthesia. 2021;

(5):655-64. https://doi.org/10.1111/anae.15317

Smith A. Donating Dantrolene: Development and

Implementation of a Malignant Hyperthermia Program in a

Scarce Resource Setting. AANA journal. 2022;90(4)

Downloads

Published

2022-10-06

How to Cite

Ali, T. ., & Kapadia, H. F. . (2022). Dilemma of Dantrolene: A life-saving drug unavailable in Pakistan. Journal of Bahria University Medical and Dental College, 12(04), 251. https://doi.org/10.51985/JBUMDC2022137

Issue

Vol. 12 No. 04 (2022): VOLUME 12 ISSUE 04

Section

Letter to Editor

License

Copyright (c) 2022 Tahir Ali, Habib Feroz Kapadia

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0